UTAH MEDICAL PRODUCTS INC
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $15.4M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $1.1M | 7.2% |
| Other Investing | $22.0K | 0.1% |
| Dividends Paid | $3.8M | 24.5% |
| Other Financing | $4.5M | 29.2% |
| Other | $1.1M | 7.2% |
| Net Cash Flow | $4.9M | 31.7% |